Purchase Order 75N91024P00367
- Not listed
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract valued at $12,821.67 to Becton, Dickinson And Company (BD) for the acquisition of a 5-laser SORP cell analyzer instrument. This instrument is currently being used by all members of the EIB (likely referring to an internal NIH program) to prevent disruption of ongoing research experiments. The contract has a completion date of July 1, 2024. BD is a...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
- This is a federal contract award to Becton, Dickinson and Company (BD) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for maintenance services on government-owned Becton Dickinson instrumentation. The $141,480.00 firm fixed-price purchase order supports the work of the NCI's Center for Cancer Research, Experimental Immunology Branch. The contract has no set-aside designation and was awarded on February 1, 2017, with a completion date of January...
- This federal contract award from the National Cancer Institute (NCI) to Becton, Dickinson And Company (BD) is for the procurement of a BD BIOSCIENCES - LSR II LASER and LSR/FORTESSA Z230SFF WORKSTATION BUNDLE SYSTEM. The $86,150.00 firm fixed-price purchase order has an ultimate completion date of August 5, 2015. The contract was awarded on May 6, 2015 and does not have a set-aside designation. BD Biosciences, a division of BD, is a major supplier of specialized biomedical research equipment and...
- This is a $764,203.60 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Becton, Dickinson & Co (BD), a large medical technology manufacturer. The contract is for a Becton Dickinson FACSymphony S6 cell sorter, which is a specialized flow cytometry instrument used for advanced medical research and clinical laboratory applications. The contract has a completion date of September 29, 2025. There is no...
- This is a $105,926.44 firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) under the FSS-66 Scientific Equipment and Services federal supply schedule. The contract is for a SERVICE AGREEMENT with a period of performance through February 28, 2025. This delivery order is not a set-aside contract. BD is a global medical technology company that provides specialized equipment,...
- This is a firm fixed price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Becton, Dickinson and Company (BD) for an Original Equipment Manufacturer (OEM) service contract for an Influx cell sorter. The contract has a ceiling value of $195,142.56 and a period of performance through April 28, 2021. BD is a global medical technology company that provides a wide range of biomedical instruments, reagents,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a one-year, firm-fixed-price purchase order worth $148,338.00 to Becton, Dickinson and Company (BD) for a service agreement to maintain two BD Biosciences S6 cell sorters and associated lasers at the Vaccine Research Center facility. The award was made on a full and open competition basis without a small business set-aside. BD, a global medical technology...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $33,675.60. The contract is for BD Biosciences, a division of BD, to provide biomedical instruments, reagents, and services that support flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
This federal contract award to Becton, Dickinson And Company (BD) is for the purchase of a 5-laser SORP cell sorter instrument to prevent disruption of ongoing research experiments at the National Cancer Institute (NCI). The $11,745.33 firm fixed-price purchase order was awarded on April 3, 2024, with an ultimate completion date of July 1, 2024. The contract does not have a set-aside designation. BD, a global medical technology company, has extensive experience providing specialized equipment and consumables to support biomedical research and clinical programs for various federal agencies, including the Department of Veterans Affairs, National Institutes of Health, and Department of Defense. This purchase order is likely part of BD's ongoing support for NCI's laboratory capabilities and research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 4/5/24 |